These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 25385061

  • 1. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF, Vieira M, Hida WT, Motta AF, Nakano CT, Nakano EM, Alves MR.
    Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
    Almeida DR, Khan Z, Xing L, Bakar SN, Rahim K, Urton T, El-Defrawy SR.
    J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
    [Abstract] [Full Text] [Related]

  • 3. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
    Miyake K, Ota I, Miyake G, Numaga J.
    J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
    [Abstract] [Full Text] [Related]

  • 4. Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.
    Ramakrishnan S, Baskaran P, Talwar B, Venkatesh R.
    Asia Pac J Ophthalmol (Phila); 2015 Sep; 4(4):216-20. PubMed ID: 26225780
    [Abstract] [Full Text] [Related]

  • 5. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Sahu S, Ram J, Bansal R, Pandav SS, Gupta A.
    J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
    [Abstract] [Full Text] [Related]

  • 6. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.
    Mathys KC, Cohen KL.
    Eye (Lond); 2010 Jan; 24(1):90-6. PubMed ID: 19229275
    [Abstract] [Full Text] [Related]

  • 7. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV, Westfield KC, Chalkley TH.
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [Abstract] [Full Text] [Related]

  • 8. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.
    Tzelikis PF, Morato CS, Neves NT, Hida WT, Alves MR.
    J Cataract Refract Surg; 2018 Apr; 44(4):440-446. PubMed ID: 29685777
    [Abstract] [Full Text] [Related]

  • 9. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
    Warren KA, Fox JE.
    Retina; 2008 Apr; 28(10):1427-34. PubMed ID: 18664937
    [Abstract] [Full Text] [Related]

  • 10. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
    Wolf EJ, Braunstein A, Shih C, Braunstein RE.
    J Cataract Refract Surg; 2007 Sep; 33(9):1546-9. PubMed ID: 17720068
    [Abstract] [Full Text] [Related]

  • 11. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
    Zaczek A, Artzen D, Laurell CG, Stenevi U, Montan P.
    J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
    [Abstract] [Full Text] [Related]

  • 12. Comparison of ketorolac 0.45% versus diclofenac 0.1% for macular thickness and volume after uncomplicated cataract surgery.
    Lee TH, Choi W, Ji YS, Yoon KC.
    Acta Ophthalmol; 2016 May; 94(3):e177-82. PubMed ID: 26072977
    [Abstract] [Full Text] [Related]

  • 13. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.
    McCafferty S, Harris A, Kew C, Kassm T, Lane L, Levine J, Raven M.
    BMC Ophthalmol; 2017 Feb 20; 17(1):16. PubMed ID: 28219426
    [Abstract] [Full Text] [Related]

  • 14. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
    Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M, Acular LS for Cystoid Macular Edema (ACME) Study Group.
    Am J Ophthalmol; 2008 Oct 20; 146(4):554-560. PubMed ID: 18599019
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.
    Ticly FG, Lira RP, Zanetti FR, Machado MC, Rodrigues GB, Arieta CE.
    J Ocul Pharmacol Ther; 2014 Aug 20; 30(6):495-501. PubMed ID: 24735005
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM, Amon M, Findl O, Kahraman G, Barisani-Asenbauer T.
    Am J Ophthalmol; 2010 May 20; 149(5):777-84. PubMed ID: 20152959
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes.
    El Gharbawy SA, Darwish EA, Abu Eleinen KG, Osman MH.
    Eur J Ophthalmol; 2019 Jul 20; 29(4):453-457. PubMed ID: 30203671
    [Abstract] [Full Text] [Related]

  • 19. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery.
    Almeida DR, Johnson D, Hollands H, Smallman D, Baxter S, Eng KT, Kratky V, ten Hove MW, Sharma S, El-Defrawy S.
    J Cataract Refract Surg; 2008 Jan 20; 34(1):64-9. PubMed ID: 18165083
    [Abstract] [Full Text] [Related]

  • 20. Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy.
    Pollack A, Staurenghi G, Sager D, Mukesh B, Reiser H, Singh RP.
    Br J Ophthalmol; 2017 Apr 20; 101(4):423-427. PubMed ID: 27388251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.